4Stary HC,Chandler AB,Dinsmore RE,et al.A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis.Circulation,1995,92:1355-1374.
5Y Stein,O Stein.Does therapeutic intervention achieve slowing of progression of Bona Fide regression of atherosclerotic lesions?Arterioscler Thromb Vasc Biol,2001,21:183.
6Gueguen G,Gaige B,Grevy JM,et al.Structure activity analysis of the effects of lysophosphatidic acid on platelet aggregation.Biochemistry,1999,38:8440-8450.
7Tokumura A,Kanaya Y,Kitahara,et al.Increased formation of lysophosphatidic acids by lysophosphalipase D in serum of hypercholesterolemic rabbits.J Lipid Res,2002,43:307-315.
8Tokumura A,Miyake M,Nishioka Y,et al.Production of lysophosphatidic acid by lysophospholipase D in human follicular fluids in vitro fertilization patients.Biol Reprod,1999,61:195-199.
9McIntyre TM,Zimmerman GA,Prescott SM.Biologically active oxidized phospholipids.J Biol Chem,1999,274:25189-25192.
10Nieholson J K, Lindon J C, Holmes E. 'Metabonomies' : understanding the metabolic responses of living systems topathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data [J]. Xenobiotica, 1999, 29 : 1181.
